George N. Lambrou - Publications

Visual acuity time in range: a novel concept to describe consistency in treatment response in diabetic macular oedema.

Journal: Eye (London, England)

Published: July 15, 2022

Patients with Neovascular Age-Related Macular Degeneration Requiring Intensive Intravitreal Aflibercept Treatment: An ARIES Post Hoc Analysis.

Journal: Ophthalmology and therapy

Published: May 04, 2022

Association Between Visual Acuity and Fluid Compartments with Treat-and-Extend Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: An ARIES Post Hoc Analysis.

Journal: Ophthalmology and therapy

Published: January 14, 2022

EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The ARIES Study: A Randomized Clinical Trial.

Journal: Retina (Philadelphia, Pa.)

Published: March 30, 2021

Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: November 26, 2020

VEGFR1 signaling in retinal angiogenesis and microinflammation.

Journal: Progress in retinal and eye research

Published: July 17, 2020

Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: April 07, 2020